Medicines Australia and Rare Cancer Australia have recently launched the Medicines Access Portal (MAP). MAP is a secure online portal that allows pharmaceutical companies to inform Australian medical practitioners of special access programs available to patients.
Compassionate access or special access programs are often the last avenue for cancer patients. Clinicians and patients have traditionally relied on general knowledge and word of mouth to find these programs.
The MAP seamlessly connects clinicians to pharmaceutical companies and offers easy access to information about medicines and treatment options for their patients.
To participate, pharmaceutical companies will register to be part of the MAP and input details of their access programs onto the website. Clinicians with an AHPRA number will register on the website to search for information on existing access programs, including the type of cancer, treatment, company, product, and company contact details. In accordance with the Therapeutic Goods Act, the general public will not be able to directly access information relating to access programs or medicines listed on the MAP.
If you have any questions regarding the MAP, please reach out to map@rarecancers.org.au.
